Regulation Can Restrict Clinician Judgment

Who decides which treatments you can access—and at what cost? Ways2Well founder Brigham Buhler joins Dr. Josh Axe to discuss pharmacy benefit managers, prescription pricing, and his fight for peptide access. They explore his FDA testimony, the debate over BPC-157 and GLP-1 medications, and his clinic’s use of plasma exchange and ozone therapy.

Learn more about your ad choices. Visit megaphone.fm/adchoices